Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
14 Dec 2023
Historique:
received: 31 05 2023
accepted: 07 12 2023
medline: 15 12 2023
pubmed: 15 12 2023
entrez: 14 12 2023
Statut: aheadofprint

Résumé

A limitation of current SARS-CoV-2 vaccines is that they provide minimal protection against infection with current Omicron subvariants

Identifiants

pubmed: 38096903
doi: 10.1038/s41586-023-06951-3
pii: 10.1038/s41586-023-06951-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Nature Limited.

Auteurs

Katherine McMahan (K)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Frank Wegmann (F)

Janssen Vaccines and Prevention B.V., Leiden, Netherlands.

Malika Aid (M)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Michaela Sciacca (M)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Jinyan Liu (J)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Nicole P Hachmann (NP)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Jessica Miller (J)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Catherine Jacob-Dolan (C)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.

Olivia Powers (O)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

David Hope (D)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Cindy Wu (C)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Juliana Pereira (J)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Tetyana Murdza (T)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Camille R Mazurek (CR)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Amelia Hoyt (A)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Adrianus C M Boon (ACM)

Washington University School of Medicine, Saint Louis, MO, USA.

Meredith Davis-Gardner (M)

Emory School of Medicine, Atlanta, GA, USA.

Mehul S Suthar (MS)

Emory School of Medicine, Atlanta, GA, USA.

Amanda J Martinot (AJ)

Tufts University Cummings School of Veterinary Medicine, North Grafton, MA, USA.

Mona Boursiquot (M)

Bioqual, Rockville, MD, USA.

Anthony Cook (A)

Bioqual, Rockville, MD, USA.

Laurent Pessaint (L)

Bioqual, Rockville, MD, USA.

Mark G Lewis (MG)

Bioqual, Rockville, MD, USA.

Jeroen Tolboom (J)

Janssen Vaccines and Prevention B.V., Leiden, Netherlands.

Jan Serroyen (J)

Janssen Vaccines and Prevention B.V., Leiden, Netherlands.

Laura Solforosi (L)

Janssen Vaccines and Prevention B.V., Leiden, Netherlands.

Lea M M Costes (LMM)

Janssen Vaccines and Prevention B.V., Leiden, Netherlands.

Roland C Zahn (RC)

Janssen Vaccines and Prevention B.V., Leiden, Netherlands.

Dan H Barouch (DH)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.
Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.

Classifications MeSH